Jacqueline Chen, DPM
Foot & Ankle Surgery · Frederick, MDNPI 1144602244
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 35.6% of the total. Reporting peaked in 2024 at $3,098 and has fallen 61.0% since, to $1,209 in 2025.
Across 125 payments — averaging $98.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Supreme Orthopedic Systems, LLC$3K
- Zimmer Biomet$2K
- Paragon 28, Inc.$1K
- Amgen$1K
- Tactile Systems Technology Inc$327
- plus $677 from 9 others
What the payments were for
- Travel & lodging$7,11958%
- Food & beverage$4,04733%
- Education$1,20010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 41 | $4,397 |
| Supreme Orthopedic Systems, LLC | 16 | $3,058 |
| Zimmer Biomet | 17 | $1,579 |
| Paragon 28, Inc. | 4 | $1,299 |
| Amgen(2 entities) | 18 | $1,029 |
| Tactile Systems Technology Inc | 16 | $327 |
| Medtronic | 3 | $201 |
| Abbott | 2 | $163 |
| GRT US Holding, Inc. | 2 | $117 |
| Dynasplint Systems Inc. | 1 | $65 |
| Evolution Surgical, Inc | 1 | $49 |
| Stryker | 1 | $33 |
| Organogenesis Inc. | 1 | $21 |
| DJO, LLC | 1 | $15 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CANNULATED SCREWS$1,167
- Portfolio$718
- KRYSTEXXA$603
- Bun-Yo-Matic$501
- Axium INS DRG IPG$134
How this compares
$12,366 in reported general payments places this provider in the 80th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 33 | $254 |
| Terbinafine Hcl | 25 | $178 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Frederick
- Adam IsaacFrederick$8K
- Damian RousselFrederick$7K
- Lew SchonBaltimore$752K
- Stuart MillerBaltimore$583K
- Mark SpierGlen Burnie$400K
- Patrick MaloneyBaltimore$262K
- Jeffrey BrodieTowson$240K
- Gregory GuytonBaltimore$216K
- Hummira AbawiColumbia$123K
- Eric HarmelinAnnapolis$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.